Reference
Richter MD, et al. Brief Report: Cancer Immunotherapy in Patients With Preexisting Rheumatic Disease: The Mayo Clinic Experience. Arthritis and Rheumatology 70: 356-360, No. 3, Mar 2018. Available from: URL: https://doi.org/10.1002/art.40397 - USA
Rights and permissions
About this article
Cite this article
Ipilimumab/nivolumab/pembrolizumab. Reactions Weekly 1697, 213 (2018). https://doi.org/10.1007/s40278-018-44769-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44769-x